Almira Dugic

Title: Almira Dugic: Innovator in C1-Esterase Inhibitor Preparation

Introduction

Almira Dugic is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of biochemistry, particularly in the development of pharmaceutical preparations. Her work focuses on creating stable C1-esterase inhibitor preparations, which are crucial for treating certain medical conditions.

Latest Patents

Almira Dugic holds 1 patent for her invention titled "C1-esterase inhibitor preparation." This patent describes a stable C1-esterase inhibitor (C1-Inh) preparation that can be either liquid or lyophilized. The preparation is characterized by a histidine content ranging from 5 to 400 mM and notably does not contain citrate or phosphate. Additionally, her invention includes a kit that features the C1-Inh preparation, enhancing its usability in medical applications.

Career Highlights

Dugic is associated with Octapharma AG, a company known for its focus on human proteins and innovative therapies. Her work at Octapharma AG has positioned her as a key player in the development of treatments that utilize C1-esterase inhibitors. Her dedication to research and innovation has contributed to advancements in therapeutic options for patients.

Collaborations

Throughout her career, Almira Dugic has collaborated with esteemed colleagues, including Georg Lattner and Klaus Tschetschkowitsch. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and development efforts.

Conclusion

Almira Dugic's contributions to the field of biochemistry, particularly through her patent for a C1-esterase inhibitor preparation, highlight her innovative spirit and commitment to improving medical treatments. Her work continues to impact the pharmaceutical industry positively.